|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar
|
|
3
|
Bertuccio P, Turati F, Carioli G,
Rodriguez T, La Vecchia C, Malvezzi M and Negri E: Global trends
and predictions in hepatocellular carcinoma mortality. J Hepatol.
67:302–309. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mak LY, Cruz-Ramón V, Chinchilla-López P,
Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK,
Bailey HH, et al: Global epidemiology, prevention, and management
of hepatocellular carcinoma. Am Soc Clin Oncol Educ Book.
38:262–279. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bosetti C, Turati F and La Vecchia C:
Hepatocellular carcinoma epidemiology. Best Pract Res Clin
Gastroenterol. 28:753–770. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Turati F, Galeone C, Rota M, Pelucchi C,
Negri E, Bagnardi V, Corrao G, Boffetta P and La Vecchia C: Alcohol
and liver cancer: A systematic review and meta-analysis of
prospective studies. Ann Oncol. 25:1526–1535. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jindal A, Thadi A and Shailubhai K:
Hepatocellular carcinoma: Etiology and current and future drugs. J
Clin Exp Hepatol. 9:221–232. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bedard PL, Hansen AR, Ratain MJ and Siu
LL: Tumour heterogeneity in the clinic. Nature. 501:355–364.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ward PS and Thompson CB: Metabolic
reprogramming: A cancer hallmark even warburg did not anticipate.
Cancer Cell. 21:297–308. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dimri M, Humphries A, Laknaur A, Elattar
S, Lee TJ, Sharma A, Kolhe R and Satyanarayana A: NAD(P)H quinone
dehydrogenase 1 ablation inhibits activation of the
phosphoinositide 3-kinase/Akt Serine/threonine kinase and
mitogen-activated protein kinase/extracellular signal-regulated
kinase pathways and blocks metabolic adaptation in hepatocellular
carcinoma. Hepatology: Jun 19, 2019 (Epub ahead of print). doi:
10.1002/hep.30818.
|
|
12
|
Liu Y, Gong W, Yang ZY, Zhou XS, Gong C,
Zhang TR, Wei X, Ma D, Ye F and Gao QL: Quercetin induces
protective autophagy and apoptosis through ER stress via the
p-STAT3/Bcl-2 axis in ovarian cancer. Apoptosis. 22:544–557.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu L, Li J, Liu T, Li S, Feng J, Yu Q,
Zhang J, Chen J, Zhou Y, Ji J, et al: Quercetin shows anti-tumor
effect in hepatocellular carcinoma LM3 cells by abrogating
JAK2/STAT3 signaling pathway. Cancer Med. 8:4806–4820.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347(1260419)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen Q, Wang L, Jiang M, Huang J, Jiang Z,
Feng H and Ji Z: E2F1 interactive with BRCA1 pathway induces HCC
two different small molecule metabolism or cell cycle regulation
via mitochondrion or CD4+ T to cytosol. J Cell Physiol.
233:1213–1221. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Goldenson B and Crispino JD: The aurora
kinases in cell cycle and leukemia. Oncogene. 34:537–545.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Schneider MA, Christopoulos P, Muley T,
Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller
NS, Theis F and Meister M: AURKA, DLGAP5, TPX2, KIF11 and CKAP5:
Five specific mitosis-associated genes correlate with poor
prognosis for non-small cell lung cancer patients. Int J Oncol.
50:365–372. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chu Z, Zhang X, Li Q, Hu G, Lian CG and
Geng S: CDC20 contributes to the development of human cutaneous
squamous cell carcinoma through the Wnt/β-catenin signaling
pathway. Int J Oncol. 54:1534–1544. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nitiss JL: DNA topoisomerase II and its
growing repertoire of biological functions. Nat Rev Cancer.
9:327–337. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Wong N, Yeo W, Wong WL, Wong NL, Chan KY,
Mo FK, Koh J, Chan SL, Chan AT, Lai PB, et al: TOP2A overexpression
in hepatocellular carcinoma correlates with early age onset,
shorter patients survival and chemoresistance. Int J Cancer.
124:644–652. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu K, Hou L, Zhu JQ, Ying XP and Yang WX:
KIFC1 participates in acrosomal biogenesis, with discussion of its
importance for the perforatorium in the Chinese mitten crab
Eriocheir sinensis. Cell Tissue Res. 337:113–123. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pawar S, Donthamsetty S, Pannu V, Rida P,
Ogden A, Bowen N, Osan R, Cantuaria G and Aneja R: KIFCI, a novel
putative prognostic biomarker for ovarian adenocarcinomas:
Delineating protein interaction networks and signaling circuitries.
J Ovarian Res. 7(53)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Han J, Wang F, Lan Y, Wang J, Nie C, Liang
Y, Song R, Zheng T, Pan S, Pei T, et al: KIFC1 regulated by
miR-532-3p promotes epithelial-to-mesenchymal transition and
metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Oncogene. 38:406–420. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen J, Rajasekaran M, Xia H, Zhang X,
Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL,
et al: The microtubule-associated protein PRC1 promotes early
recurrence of hepatocellular carcinoma in association with the
Wnt/β-catenin signalling pathway. Gut. 65:1522–1534.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Subramanian R, Wilson-Kubalek EM, Arthur
CP, Bick MJ, Campbell EA, Darst SA, Milligan RA and Kapoor TM:
Insights into antiparallel microtubule crosslinking by PRC1, a
conserved nonmotor microtubule binding protein. Cell. 142:433–443.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang SM, Ooi LL and Hui KM: Upregulation
of Rac GTPase-activating protein 1 is significantly associated with
the early recurrence of human hepatocellular carcinoma. Clin Cancer
Res. 17:6040–6051. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Verhey KJ and Hammond JW: Traffic control:
Regulation of kinesin motors. Nat Rev Mol Cell Biol. 10:765–777.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Shi C, Huang D, Lu N, Chen D, Zhang M, Yan
Y, Deng L, Lu Q, Lu H and Luo S: Aberrantly activated Gli2-KIF20A
axis is crucial for growth of hepatocellular carcinoma and predicts
poor prognosis. Oncotarget. 7:26206–26219. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Imaoka H, Toiyama Y, Saigusa S, Kawamura
M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Inoue Y, Mohri Y and
Kusunoki M: RacGAP1 expression, increasing tumor malignant
potential, as a predictive biomarker for lymph node metastasis and
poor prognosis in colorectal cancer. Carcinogenesis. 36:346–354.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Saigusa S, Tanaka K, Mohri Y, Ohi M,
Shimura T, Kitajima T, Kondo S, Okugawa Y, Toiyama Y, Inoue Y and
Kusunoki M: Clinical significance of RacGAP1 expression at the
invasive front of gastric cancer. Gastric Cancer. 18:84–92.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yang XM, Cao XY, He P, Li J, Feng MX,
Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, et al: Overexpression
of Rac GTPase activating protein 1 contributes to proliferation of
cancer cells by reducing hippo signaling to promote cytokinesis.
Gastroenterology. 155:1233–1249, e22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zou H, McGarry TJ, Bernal T and Kirschner
MW: Identification of a vertebrate sister-chromatid separation
inhibitor involved in transformation and tumorigenesis. Science.
285:418–422. 1999.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Molina-Jiménez F, Benedicto I, Murata M,
Martin-Vilchez S, Seki T, Antonio Pintor-Toro J, Tortolero M,
Moreno-Otero R, Okazaki K, Koike K, et al: Expression of pituitary
tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus
(HBV)-associated liver diseases: Evidence for an HBV X
protein-mediated inhibition of PTTG1 ubiquitination and
degradation. Hepatology. 51:777–787. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tian Y, Wu J, Chagas C, Du Y, Lyu H, He Y,
Qi S, Peng Y and Hu J: CDCA5 overexpression is an Indicator of poor
prognosis in patients with hepatocellular carcinoma (HCC). BMC
Cancer. 18(1187)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rape M and Kirschner MW: Autonomous
regulation of the anaphase-promoting complex couples mitosis to
S-phase entry. Nature. 432:588–595. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fernandez Esmerats J, Villa-Roel N, Kumar
S, Gu L, Salim MT, Ohh M, Taylor WR, Nerem RM, Yoganathan AP and Jo
H: Disturbed flow increases UBE2C (Ubiquitin E2 Ligase C) via loss
of miR-483-3p, inducing aortic valve calcification by the pVHL (von
Hippel-Lindau protein) and HIF-1α (hypoxia-inducible factor-1α)
pathway in endothelial cells. Arterioscler Thromb Vasc Biol.
39:467–481. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Xia H, Kong SN, Chen J, Shi M, Sekar K,
Seshachalam VP, Rajasekaran M, Goh BKP, Ooi LL and Hui KM: MELK is
an oncogenic kinase essential for early hepatocellular carcinoma
recurrence. Cancer Lett. 383:85–93. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Blot J, Chartrain I, Roghi C, Philippe M
and Tassan JP: Cell cycle regulation of pEg3, a new Xenopus protein
kinase of the KIN1/PAR-1/MARK family. Dev Biol. 241:327–338.
2002.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hussain MS, Battaglia A, Szczepanski S,
Kaygusuz E, Toliat MR, Sakakibara S, Altmüller J, Thiele H,
Nürnberg G, Moosa S, et al: Mutations in CKAP2L, the human homolog
of the mouse Radmis gene, cause Filippi syndrome. Am J Hum Genet.
95:622–632. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Xiong G, Li L, Chen X, Song S, Zhao Y, Cai
W and Peng J: Up-regulation of CKAP2L expression promotes lung
adenocarcinoma invasion and is associated with poor prognosis. Onco
Targets Ther. 12:1171–1180. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen J, Zhu F, Weaks RL, Biswas AK, Guo R,
Li Y and Johnson DG: E2F1 promotes the recruitment of DNA repair
factors to sites of DNA double-strand breaks. Cell Cycle.
10:1287–1294. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang H, Shao N, Ding QM, Cui J, Reddy ES
and Rao VN: BRCA1 proteins are transported to the nucleus in the
absence of serum and splice variants BRCA1a, BRCA1b are tyrosine
phosphoproteins that associate with E2F, cyclins and cyclin
dependent kinases. Oncogene. 15:143–157. 1997.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Li R, Jiang X, Zhang Y, Wang S, Chen X, Yu
X, Ma J and Huang X: Cyclin B2 overexpression in human
hepatocellular carcinoma is associated with poor prognosis. Arch
Med Res. 50:10–17. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wu T, Zhang X, Huang X, Yang Y and Hua X:
Regulation of cyclin B2 expression and cell cycle G2/m transition
by menin. J Biol Chem. 285:18291–18300. 2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Raemaekers T, Ribbeck K, Beaudouin J,
Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg
J and Carmeliet G: NuSAP, a novel microtubule-associated protein
involved in mitotic spindle organization. J Cell Biol.
162:1017–1029. 2003.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gulzar ZG, McKenney JK and Brooks JD:
Increased expression of NuSAP in recurrent prostate cancer is
mediated by E2F1. Oncogene. 32:70–77. 2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhu X, Shi C, Peng Y, Yin L, Tu M, Chen Q,
Hou C, Li Q and Miao Y: Thymidine kinase 1 silencing retards
proliferative activity of pancreatic cancer cell via E2F1-TK1-P21
axis. Cell Prolif. 51(e12428)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Mao R, Liu J, Liu G, Jin S, Xue Q, Ma L,
Fu Y, Zhao N, Xing J, Li L, et al: Whole genome sequencing of
matched tumor, adjacent non-tumor tissues and corresponding normal
blood samples of hepatocellular carcinoma patients revealed dynamic
changes of the mutations profiles during hepatocarcinogenesis.
Oncotarget. 8:26185–26199. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kauffman MG and Kelly TJ: Cell cycle
regulation of thymidine kinase: Residues near the carboxyl terminus
are essential for the specific degradation of the enzyme at
mitosis. Mol Cell Biol. 11:2538–2546. 1991.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ke PY and Chang ZF: Mitotic degradation of
human thymidine kinase 1 is dependent on the anaphase-promoting
complex/cyclosome-CDH1-mediated pathway. Mol Cell Biol. 24:514–526.
2004.PubMed/NCBI View Article : Google Scholar
|
